Article Sidebar

PDF (Tiếng Việt)
Published: 2024-06-10
Abstract Views: 95
Views PDF (Tiếng Việt): 32
DOI: https://doi.org/10.52163/yhc.v65i4.1199
Issue
Vol. 65 No. 4
Section
Articles
How to Cite
Bá, H. V. ., Cúc, H. B. ., Nguyên, N. V. ., & Trâm, P. T. B. . (2024). 12. SOME ANXIETY FACTORS IN FCAD PATIENTS TREATED WITH MEDLO AND SENSIVE SERUM AT FOB DERMATOLOGY SPECIALIZED CLINIC IN 2022-2023. Vietnam Journal of Community Medicine, 65(4). https://doi.org/10.52163/yhc.v65i4.1199

12. SOME ANXIETY FACTORS IN FCAD PATIENTS TREATED WITH MEDLO AND SENSIVE SERUM AT FOB DERMATOLOGY SPECIALIZED CLINIC IN 2022-2023

Huynh Van Ba1, Huynh Bach Cuc2, Nguyen Van Nguyen3, Pham Thi Bao Tram1
1 Can Tho University of Medicine and Pharmacy
2 Nguyen Tri Phuong Hospital
3 FOB Vocational Beauty Center

Main Article Content

Abstract

Objectives: Describes some factors related to the anxiety of FCAD patients treated with medlo and intensive serum at the Fob dermatology clinic in 2022-2023.


Materials and method: A cross-sectional descriptive study was conducted on 85 patients diagnosed with facial corticosteroid addictive dermatitis (FCAD) who came for examination and treatment at the Fob dermatology clinic from July 2022 to May 2023.


Results: Patients with paraanxiety disorder have a rate of 10.6%, and those with anxiety have a rate of 34.1%. There was a change in the rate of anxiety disorders after 12 weeks of treatment: the rate of anxiety before treatment was 34.1% and decreased (16.5%).


Conclusion: When treating FCAD patients, it is necessary to pay attention to anxiety disorders in patients, especially those who work mentally and live in cities.

Article Details

Keywords

FCAD, anxiety, dipotassium glycyrrhizinate, treatment.

References

[1] Abraham A, G Roga, Topical steroid-damaged
skin, Indian J Dermatol, 59(5), 2014, pp. 456-9.
[2] Guo F, Q Yu, Z Liu et al., Evaluation of life
quality, anxiety, and depression in patients with
skin diseases, Medicine (Baltimore), 99(44),
2020, pp. e22983.
[3] Liu ZH, XH Du, Quality of life in patients with
facial steroid dermatitis before and after
treatment, J Eur Acad Dermatol Venereol, 22(6),
2008, pp. 663-9.
[4] Molla A, H Alrizqi, E Alharbi et al., Assessment of
Anxiety and Depression in Patients with Acne
Vulgaris in Medina: A Case-Control Study, Clin
Cosmet Investig Dermatol, 14, 2021, pp. 999-1007.
[5] Sun C, Y Ren, W Zhang, Association between skin
disease and anxiety: a logistic analysis and
prediction, Ann Transl Med, 11(2), 2023, pp. 115.
[6] Feleke ZT, Mahelet DN, Awel A et al., Topical
corticosteroid misuse among females attending a
dermatology outpatient department in Ethiopia,
Trichol Cos-metol Open J, 2017, pp. 33-36.